News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
582,024 Results
Type
Article (19097)
Company Profile (167)
Press Release (562757)
Multimedia
Podcasts (81)
Webinars (13)
Section
Business (198503)
Career Advice (703)
Deals (30760)
Drug Delivery (93)
Drug Development (65704)
Employer Resources (54)
FDA (12405)
Job Trends (11105)
News (288036)
Policy (24161)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Digital (1)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (823)
Accelerated approval (44)
ADA (26)
Adcomms (10)
Allergies (145)
Alliances (41819)
ALS (145)
Alzheimer's disease (1279)
Antibody-drug conjugate (ADC) (360)
Approvals (13059)
Artificial intelligence (519)
ASCO (219)
Autoimmune disease (255)
Automation (40)
Bankruptcy (321)
Best Places to Work (8373)
BIO (47)
Biologics (2)
BIOSECURE Act (10)
Biosimilars (195)
BioSpace Insights (77)
Biotechnology (102)
Bladder cancer (156)
Brain cancer (57)
Breast cancer (611)
Cancer (4535)
Cardiovascular disease (362)
Career advice (608)
Career pathing (15)
CAR-T (221)
CDC (8)
CDMO (56)
Celiac Disease (1)
Cell therapy (614)
Cervical cancer (41)
Clinical research (58989)
Collaboration (1747)
Commercialization (5)
Company closure (3)
Compensation (1503)
Complete response letters (61)
COVID-19 (1288)
CRISPR (85)
C-suite (1085)
Cystic fibrosis (126)
Data (6732)
Decentralized trials (1)
Denatured (23)
Depression (125)
Dermatology (71)
Diabetes (445)
Diagnostics (4842)
Digital health (46)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (274)
Drug pricing (126)
Drug shortages (15)
Duchenne muscular dystrophy (234)
Earnings (81495)
Editorial (25)
Employer branding (5)
Employer resources (50)
Events (99414)
Executive appointments (974)
FDA (15625)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (20)
Frontotemporal dementia (28)
Funding (1245)
Gene editing (167)
Generative AI (35)
Gene therapy (467)
GLP-1 (678)
Government (2025)
Grass and pollen (5)
Guidances (332)
Healthcare (11063)
Hematology (128)
HIV (56)
Huntington's disease (28)
IgA nephropathy (100)
Immunology and inflammation (171)
Immuno-oncology (80)
Indications (196)
Infectious disease (1521)
Inflammatory bowel disease (173)
Inflation Reduction Act (9)
Influenza (98)
Intellectual property (302)
Interviews (94)
IPO (13979)
IRA (33)
Job creations (3105)
Job search strategy (550)
JPM (29)
Kidney cancer (20)
Labor market (40)
Layoffs (254)
Leadership (11)
Legal (6587)
Licensing (13)
Liver cancer (55)
Longevity (25)
Lung cancer (643)
Lymphoma (347)
Machine learning (35)
Management (18)
Manufacturing (938)
Marketing (12)
MASH (164)
Medical affairs (1)
Medical device (9270)
Medtech (9426)
Mergers & acquisitions (17968)
Metabolic disorders (1077)
mRNA (115)
Multiple sclerosis (140)
NASH (15)
Neurodegenerative disease (300)
Neuropsychiatric disorders (74)
Neuroscience (2456)
Neurotech (1)
NextGen: Class of 2026 (3895)
Non-profit (1265)
Now hiring (24)
Obesity (434)
Opinion (158)
Ovarian cancer (177)
Pain (247)
Pancreatic cancer (232)
Parkinson's disease (279)
Partnered (21)
Patents (593)
Patient recruitment (607)
Peanut (39)
People (50770)
Pharmaceutical (45)
Pharmacy benefit managers (23)
Phase 1 (18191)
Phase 2 (25935)
Phase 3 (19248)
Pipeline (8933)
Policy (166)
Postmarket research (2127)
Preclinical (7545)
Press Release (49)
Prostate cancer (238)
Psychedelics (31)
Radiopharmaceuticals (272)
Rare diseases (865)
Real estate (4464)
Recruiting (20)
Regulatory (19829)
Reports (28)
Research institute (961)
Resumes & cover letters (95)
Rett syndrome (43)
RNA editing (12)
RSV (53)
Schizophrenia (148)
Series A (227)
Series B (158)
Service/supplier (5)
Sickle cell disease (99)
Special edition (11)
Spinal muscular atrophy (113)
Sponsored (16)
Startups (2782)
State (2)
Stomach cancer (9)
Supply chain (97)
Tariffs (71)
The Weekly (56)
Vaccines (525)
Venture capital (56)
Weight loss (230)
Women's health (105)
Worklife (4)
Date
Today (88)
Last 7 days (346)
Last 30 days (1841)
Last 365 days (23060)
2026 (15462)
2025 (23308)
2024 (27248)
2023 (31378)
2022 (40754)
2021 (43348)
2020 (39852)
2019 (29682)
2018 (22645)
2017 (24679)
2016 (23534)
2015 (29454)
2014 (25700)
2013 (22103)
2012 (24119)
2011 (24451)
2010 (23679)
Location
Africa (467)
Alabama (82)
Alaska (2)
Arizona (348)
Arkansas (13)
Asia (30217)
Australia (4151)
California (12770)
Canada (3491)
China (1062)
Colorado (515)
Connecticut (470)
Delaware (275)
Europe (54730)
Florida (1953)
Georgia (416)
Hawaii (3)
Idaho (49)
Illinois (863)
India (100)
Indiana (561)
Iowa (16)
Japan (574)
Kansas (119)
Kentucky (37)
Louisiana (31)
Maine (28)
Maryland (1376)
Massachusetts (8747)
Michigan (325)
Minnesota (608)
Mississippi (5)
Missouri (106)
Montana (27)
Nebraska (16)
Nevada (119)
New Hampshire (68)
New Jersey (3214)
New Mexico (18)
New York (3125)
North Carolina (1541)
North Dakota (4)
Northern California (6410)
Ohio (306)
Oklahoma (17)
Oregon (29)
Pennsylvania (2420)
Puerto Rico (26)
Rhode Island (36)
South America (732)
South Carolina (80)
South Dakota (1)
Southern California (5262)
Tennessee (149)
Texas (2056)
United States (43230)
Utah (389)
Vermont (1)
Virginia (270)
Washington D.C. (51)
Washington State (992)
West Virginia (2)
Wisconsin (109)
Wyoming (2)
582,024 Results for "arrowhead pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Arrowhead’s new Redemplo findings in severe hypertriglyceridemia have analysts split
Safety and dosing are likely to be “key differentiators” for Arrowhead Pharmaceuticals as it looks to challenge Ionis Pharmaceuticals’ lead in the severe hypertriglyceridemia market.
August 31, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher
August 4, 2026
·
6 min read
Rare diseases
Arrowhead puts pressure on Ionis with positive data for triglyceride lowering drug
With Phase 3 data showing what analysts called a “potentially best-in-class profile,” Arrowhead Pharmaceuticals plans to submit for FDA approval of plozasiran by the end of the year—hoping to follow to market Ionis Pharmaceuticals’ Tryngolza, which got the regulator’s nod in severe hypertriglyceridemia last month.
July 22, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Arrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results
August 4, 2026
·
12 min read
Press Releases
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Third Quarter Results
July 21, 2026
·
4 min read
Press Releases
Arrowhead Pharmaceuticals to Present New Clinical Data at the European Society of Cardiology Congress
August 24, 2026
·
9 min read
Press Releases
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - August 3, 2026
August 3, 2026
·
3 min read
MASH
Madrigal picks up another siRNA asset for MASH, betting up to $1B with Arrowhead
Madrigal Pharmaceuticals has licensed from Arrowhead Pharmaceuticals an RNA interference candidate that targets a genetic mutation present in around 30% of patients with MASH.
May 5, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events
June 2, 2026
·
4 min read
Press Releases
Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia
August 30, 2026
·
12 min read
1 of 58,203
Next
